104 related articles for article (PubMed ID: 38775437)
1. The Global Reading Room: Imaging in Monoclonal Gammopathy of Undetermined Significance.
Chang CY; Jung JY; Moulopoulos LA; Wennmann M
AJR Am J Roentgenol; 2024 May; ():. PubMed ID: 38775437
[No Abstract] [Full Text] [Related]
2. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.
van de Donk NW; Palumbo A; Johnsen HE; Engelhardt M; Gay F; Gregersen H; Hajek R; Kleber M; Ludwig H; Morgan G; Musto P; Plesner T; Sezer O; Terpos E; Waage A; Zweegman S; Einsele H; Sonneveld P; Lokhorst HM;
Haematologica; 2014 Jun; 99(6):984-96. PubMed ID: 24658815
[TBL] [Abstract][Full Text] [Related]
3. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
Cowan A; Ferrari F; Freeman SS; Redd R; El-Khoury H; Perry J; Patel V; Kaur P; Barr H; Lee DJ; Lightbody E; Downey K; Argyelan D; Theodorakakou F; Fotiou D; Liacos CI; Kanellias N; Chavda SJ; Ainley L; Sandecká V; Pospíšilová L; Minarik J; Jungova A; Radocha J; Spicka I; Nadeem O; Yong K; Hájek R; Kastritis E; Marinac CR; Dimopoulos MA; Get G; Trippa L; Ghobrial IM
Lancet Haematol; 2023 Mar; 10(3):e203-e212. PubMed ID: 36858677
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
[TBL] [Abstract][Full Text] [Related]
5. Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
Schmitz MF; Otten HG; Franssen LE; van Dorp S; Strooisma T; Lokhorst HM; van de Donk NW
Haematologica; 2014 Dec; 99(12):1846-53. PubMed ID: 25193963
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.
Kristinsson SY; Tang M; Pfeiffer RM; Björkholm M; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Haematologica; 2012 Jun; 97(6):854-8. PubMed ID: 22180421
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review.
Kaur J; Valisekka SS; Hameed M; Bandi PS; Varma S; Onwughalu CJ; Ibrahim H; Mongia H
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):e195-e212. PubMed ID: 36966041
[TBL] [Abstract][Full Text] [Related]
9. Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.
Kristinsson SY; Björkholm M; Andersson TM; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Haematologica; 2009 Dec; 94(12):1714-20. PubMed ID: 19608666
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
[TBL] [Abstract][Full Text] [Related]
11. Leukocytoclastic vasculitis associated with immunoglobulin A lambda monoclonal gammopathy of undetermined significance: A case report and review of previously reported cases.
Umemura H; Yamasaki O; Iwatsuki K
J Dermatol; 2018 Aug; 45(8):1009-1012. PubMed ID: 29766549
[TBL] [Abstract][Full Text] [Related]
12. Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper.
Stern S; Chaudhuri S; Drayson M; Henshaw S; Karunanithi K; Willis F;
Br J Haematol; 2023 Aug; 202(4):734-744. PubMed ID: 37587091
[TBL] [Abstract][Full Text] [Related]
13. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
[TBL] [Abstract][Full Text] [Related]
14. Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells.
Hellqvist E; Kvarnström M; Söderberg A; Vrethem M; Ernerudh J; Rosén A
Haematologica; 2010 Apr; 95(4):627-36. PubMed ID: 20015874
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
[TBL] [Abstract][Full Text] [Related]
16. A case of immunotactoid glomerulopathy in a patient with monoclonal gammopathy of renal significance.
Campdesuner V; Teklie Y; Lattanzio N; Lorenzo C; Bell S; Rodriguez Y; Sastry A
J Community Hosp Intern Med Perspect; 2021 Jan; 11(1):60-64. PubMed ID: 33552417
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
18. The "Undetermined Significance" of
Treglia G; Bertagna F; Albano D
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441062
[TBL] [Abstract][Full Text] [Related]
19. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen.
Kumutpongpanich T; Owattanapanich W; Tanboon J; Nishino I; Boonyapisit K
Neuromuscul Disord; 2018 Jul; 28(7):610-613. PubMed ID: 29910095
[TBL] [Abstract][Full Text] [Related]
20. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
Varettoni M; Zibellini S; Defrancesco I; Ferretti VV; Rizzo E; Malcovati L; Gallì A; Porta MGD; Boveri E; Arcaini L; Candido C; Paulli M; Cazzola M
Haematologica; 2017 Dec; 102(12):2077-2085. PubMed ID: 28983055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
